GSA CAPITAL PARTNERS LLP

Position in BMY — Bristol Myers Squibb Co

CIK 1362033 LONDON, X0

Position in BMY

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,665,102

-$1,112,065 QoQ

Shares Held

28,898

-53.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#912

of 2,506 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $7,172,969 across 8 Drug Manufacturers - General names. BMY ranks #1 (23.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co This page	28,898	$1,665,102
2	LLY	ELI LILLY & Co	1,075	$1,289,387
3	GILD	Gilead Sciences, Inc.	9,877	$1,247,860
4	AMGN	Amgen Inc	2,641	$956,358
5	GRFS	Grifols SA	101,833	$720,977
6	SNY	Sanofi	12,660	$540,075
7	NVS	Novartis AG	2,762	$432,860
8	MRK	Merck & Co., Inc.	2,493	$320,350

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,665,102	28,898	-53.1%	Shares	Sole	2026-08-06
2025-09-30	$2,777,167	61,578	+30.1%	Shares	Sole	2025-11-07
2025-06-30	$2,190,350	47,318	+604.9%	Shares	Sole	2025-07-22
2025-03-31	$409,425	6,713	-12.5%	Shares	Sole	2025-05-08
2024-09-30	$396,897	7,671	-23.2%	Shares	Sole	2024-11-05
2024-06-30	$414,843	9,989	-84.9%	Shares	Sole	2024-08-15
2023-12-31	$3,401,134	66,286	+4.1%	Shares	Sole	2024-02-16
2023-09-30	$3,696,335	63,686	+128.2%	Shares	Sole	2023-11-15
2022-06-30	$2,149,070	27,910	+860.8%	Shares	Sole	2022-08-09
2022-03-31	$212,152	2,905	-74.6%	Shares	Sole	2022-05-11
2021-12-31	$711,849	11,417	+70.8%	Shares	Sole	2022-02-14
2021-09-30	$395,551	6,685	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.